Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by MikeyHon Aug 27, 2020 9:31am
99 Views
Post# 31459651

RE:RE:RE:RE:RE:RE:RE:Symptomatic vs Asymptomatic

RE:RE:RE:RE:RE:RE:RE:Symptomatic vs AsymptomaticTrolls?

Listen, there is very little "educated" about your guesses my friend. When someone turns up asking questions you don't like to consider, you turn round and label them trolls and bashers and bury your head in the sand. All I'm interested in is seeing the best possible tests get onto the market. We desperately need them.

And as for Findingmoney's great insight. Abbott is an ENORMOUS company, with resources you couldn't dream of. Of course they will have multiple tests under development at any one time - this will have been in development for as long as Sonas undoubtedly, with hundreds of scientists working round the clock. But the real difference is they have managed a large, multi-center clinical study at leading US institutions. Hence, FDA approval.

Bullboard Posts